{"id": "1381440893291393026", "creation": 1618196149.0, "user_id": "338736117", "social_network": "twitter", "nsfw": false, "request": ["b26b9dbc-1c5a-4cd3-a3a6-c2f5a51ad0fc"], "metrics": {"b26b9dbc-1c5a-4cd3-a3a6-c2f5a51ad0fc": {"retweet_count": 6, "reply_count": 0, "like_count": 17, "quote_count": 1}}, "text": "#China has approved the third #COVID19 #vaccine from #Sinopharm to start clinical trials, the company said on Saturday. \n\nThe latest one is a #recombinant vaccine that uses genetic engineering to grow harmless copies of the virus S-protein to induce neutralizing antibodies. https://t.co/asJSz435nU", "first_save": 1634559108.199414, "hashtags": ["#CHINA", "#COVID19", "#VACCINE", "#SINOPHARM", "#RECOMBINANT"]}